The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Eisai
Expert Testimony - Eisai
Circulating tumor cells (CTCs) in patients with HER2-negative recurrent or metastatic breast cancer treated with eribulin as third-line therapy: ONSITE trial (OncoSur Analysis of the Treatment in Third Line of ABC with Eribulin).
 
Luis Manso
No Relationships to Disclose
 
Fernando Moreno
No Relationships to Disclose
 
Juan Ignacio Delgado Mingorance
No Relationships to Disclose
 
Maria Jose Echarri
No Relationships to Disclose
 
Ana Lopez-Gonzalez
No Relationships to Disclose
 
Yann Izarzugaza
No Relationships to Disclose
 
Pablo Borrega
No Relationships to Disclose
 
Noelia Martínez
No Relationships to Disclose
 
Clara Olier
No Relationships to Disclose
 
Ana Isabel Ballesteros Garcia
No Relationships to Disclose
 
Jose Ignacio Chacon
No Relationships to Disclose
 
Eva Ciruelos
No Relationships to Disclose
 
Tomas Pascual
No Relationships to Disclose
 
Luis Paz-Ares
No Relationships to Disclose